Deutsche Bank’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $380K | Buy |
109,787
+39,018
| +55% | +$135K | ﹤0.01% | 2590 |
|
|
2025
Q1 | $185K | Sell |
70,769
-11,691
| -14% | -$30.6K | ﹤0.01% | 2959 |
|
|
2024
Q4 | $340K | Buy |
82,460
+30,278
| +58% | +$125K | ﹤0.01% | 2791 |
|
|
2024
Q3 | $369K | Buy |
52,182
+14,212
| +37% | +$101K | ﹤0.01% | 2582 |
|
|
2024
Q2 | $248K | Sell |
37,970
-13,645
| -26% | -$89K | ﹤0.01% | 2653 |
|
|
2024
Q1 | $428K | Buy |
51,615
+1,248
| +2% | +$10.4K | ﹤0.01% | 2384 |
|
|
2023
Q4 | $555K | Sell |
50,367
-1,412
| -3% | -$15.5K | ﹤0.01% | 2297 |
|
|
2023
Q3 | $435K | Buy |
51,779
+6,119
| +13% | +$51.5K | ﹤0.01% | 2233 |
|
|
2023
Q2 | $573K | Sell |
45,660
-111,683
| -71% | -$1.4M | ﹤0.01% | 2278 |
|
|
2023
Q1 | $2.59M | Sell |
157,343
-79,621
| -34% | -$1.31M | ﹤0.01% | 1541 |
|
|
2022
Q4 | $3.54M | Sell |
236,964
-153,144
| -39% | -$2.29M | ﹤0.01% | 1359 |
|
|
2022
Q3 | $8.73M | Buy |
390,108
+230,993
| +145% | +$5.17M | 0.01% | 1002 |
|
|
2022
Q2 | $2.67M | Buy |
159,115
+61,336
| +63% | +$1.03M | ﹤0.01% | 1602 |
|
|
2022
Q1 | $2.93M | Sell |
97,779
-2,439
| -2% | -$73K | ﹤0.01% | 1671 |
|
|
2021
Q4 | $3.08M | Buy |
100,218
+57,417
| +134% | +$1.76M | ﹤0.01% | 1714 |
|
|
2021
Q3 | $1.35M | Buy |
42,801
+3,912
| +10% | +$123K | ﹤0.01% | 2412 |
|
|
2021
Q2 | $1.42M | Buy |
38,889
+7,144
| +23% | +$261K | ﹤0.01% | 2530 |
|
|
2021
Q1 | $1.1M | Buy |
31,745
+6,608
| +26% | +$229K | ﹤0.01% | 2595 |
|
|
2020
Q4 | $1.04M | Buy |
25,137
+7,922
| +46% | +$329K | ﹤0.01% | 2401 |
|
|
2020
Q3 | $733K | Buy |
+17,215
| New | +$733K | ﹤0.01% | 2387 |
|